Safety signals identified through extended follow-up include: Gastrointestinal effects : Nausea, vomiting, and diarrhea remain the most common adverse events, typically diminishing over time but causing discontinuation in approximately 57% of patients Gallbladder disease : Increased incidence of cholelithiasis and cholecystitis, possibly associated with weight loss, though the exact mechanism remains under investigation Diabetic retinopathy : Risk of complications, particularly with rapid glycemic improvement in patients with pre-existing retinopathy Acute kidney injury : Risk associated with severe gastrointestinal adverse events leading to dehydration Pancreatitis : Rare cases reported, though causality remains uncertain
Evidence is mixed but potentially helpful and safe
Vitamin C Injection 2ml 500mg Ascorbic acid ampoule Use of this product should be done under professional supervision and consultation with your doctor
Thus, in embodiments of the invention, one or more HGF mimics may be used in combination with one or more different bioactive drugs
Preclinical research has investigated BPC-157 for a wide range of applications, including gastrointestinal healing (ulcers, NSAID-induced gut damage, intestinal permeability), tendon and ligament repair, muscle recovery from crush injuries, peripheral nerve regeneration, and neuroprotection